Published in Presse Med on June 05, 1993
Severe strongyloidiasis: a systematic review of case reports. BMC Infect Dis (2013) 1.70
In vitro and in vivo activities of moxifloxacin and clinafloxacin against Mycobacterium tuberculosis. Antimicrob Agents Chemother (1998) 3.02
Detection of IgG antibodies to lymphadenopathy-associated virus in patients with AIDS or lymphadenopathy syndrome. Lancet (1984) 2.56
Imported Falciparum malaria in Europe: sentinel surveillance data from the European network on surveillance of imported infectious diseases. Clin Infect Dis (2002) 2.44
Escherichia coli native valve endocarditis. Clin Microbiol Infect (2006) 2.28
HIV transmission by oral sex. Lancet (1988) 2.27
Tuberculosis in HIV-infected patients: a comprehensive review. Clin Microbiol Infect (2004) 2.13
[Management of pregnant women infected with HIV at Bichat Hospital between 1990 and 1998: analysis of 202 pregnancies]. Gynecol Obstet Fertil (2001) 2.05
[Mode of delivery of HIV-infected women: a retrospective study of 358 pregnancies followed in the same hospital between 2000 and 2004]. Gynecol Obstet Fertil (2006) 2.03
Virus excretion in the cervicovaginal secretions of pregnant and nonpregnant HIV-infected women. J Acquir Immune Defic Syndr (1993) 1.91
Epidemiology and clinical features of vivax malaria imported to Europe: sentinel surveillance data from TropNetEurop. Malar J (2004) 1.90
The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study. Hepatology (2001) 1.87
Cellular and plasma viral load in patients infected with HIV-2. AIDS (1993) 1.76
Albendazole as a potential treatment for human hydatidosis. Lancet (1983) 1.62
Hepatitis B virus DNA sequences in lymphoid cells from patients with AIDS and AIDS-related complex. Science (1985) 1.60
Six epitopes reacting with human cytotoxic CD8+ T cells in the central region of the HIV-1 NEF protein. J Immunol (1991) 1.60
Effect of indinavir on HIV-related wasting. AIDS (1998) 1.59
Malaria risk perception, knowledge and prophylaxis practices among travellers of African ethnicity living in Paris and visiting their country of origin in sub-Saharan Africa. Trans R Soc Trop Med Hyg (2007) 1.53
HIV-2 integrase gene polymorphism and phenotypic susceptibility of HIV-2 clinical isolates to the integrase inhibitors raltegravir and elvitegravir in vitro. J Antimicrob Chemother (2008) 1.47
Qualitative and quantitative analysis of human cytotoxic T-lymphocyte responses to HIV-1 proteins. AIDS (1992) 1.47
Factors of weight loss in patients with HIV and chronic diarrhea. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.45
An antigenic peptide of the HIV-1 NEF protein recognized by cytotoxic T lymphocytes of seropositive individuals in association with different HLA-B molecules. Eur J Immunol (1989) 1.43
Variability of human immunodeficiency virus type 2 (hiv-2) infecting patients living in france. Virology (2001) 1.40
HFRS after a wild rodent bite in the Haute-Savoie--and risk of exposure to Hantaan-like virus in a Paris laboratory. Lancet (1984) 1.38
[Plasmodium falciparum malaria: type R1 resistance to quinine in west Africa]. Presse Med (1998) 1.38
Detection of Toxoplasma gondii in venous blood from AIDS patients by polymerase chain reaction. J Clin Microbiol (1993) 1.35
Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study Group. N Engl J Med (1993) 1.35
Clinical and echocardiographic observations in pulmonary valve endocarditis. Am J Cardiol (1985) 1.33
Intestinal infections in patients with acquired immunodeficiency syndrome. A prospective study in 132 patients. Dig Dis Sci (1989) 1.33
Age as a risk factor for severe manifestations and fatal outcome of falciparum malaria in European patients: observations from TropNetEurop and SIMPID Surveillance Data. Clin Infect Dis (2003) 1.29
Polymorphism of the human immunodeficiency virus type 2 (HIV-2) protease gene and selection of drug resistance mutations in HIV-2-infected patients treated with protease inhibitors. J Clin Microbiol (2005) 1.29
Epidemiology of invasive aspergillosis in France: a six-year multicentric survey in the Greater Paris area. J Hosp Infect (2002) 1.28
Efficacy and tolerance of intravitreal ganciclovir in cytomegalovirus retinitis in acquired immune deficiency syndrome. Ophthalmology (1991) 1.28
Serum immunoglobulin G subclass dysbalances in the lymphadenopathy syndrome and acquired immune deficiency syndrome. Clin Exp Immunol (1986) 1.28
The comparative efficacy and tolerability of CGP 56697 (artemether + lumefantrine) versus halofantrine in the treatment of uncomplicated falciparum malaria in travellers returning from the Tropics to The Netherlands and France. Int J Antimicrob Agents (1999) 1.27
Dengue type 3 virus infections in European travellers returning from the Comoros and Zanzibar, February-April 2010. Euro Surveill (2010) 1.22
Effects of zidovudine in 365 consecutive patients with AIDS or AIDS-related complex. Lancet (1988) 1.21
Risk factors for negative sputum acid-fast bacilli smears in pulmonary tuberculosis: results from Dakar, Senegal, a city with low HIV seroprevalence. Int J Tuberc Lung Dis (1999) 1.20
[Plasmodium falciparum: interpretation of the semi-microtest of in vitro chemosensitivity by H3-hypoxanthine incorporation]. Pathol Biol (Paris) (1984) 1.20
Quantification of proviral load of human immunodeficiency virus type 2 subtypes A and B using real-time PCR. J Clin Microbiol (2001) 1.19
Acute renal failure in the course of HIV infection: a single-institution retrospective study of ninety-two patients and sixty renal biopsies. Nephrol Dial Transplant (1999) 1.15
Cutaneous larva migrans in travelers: a prospective study, with assessment of therapy with ivermectin. Clin Infect Dis (2000) 1.12
Cytomegalovirus colitis in patients with acquired immunodeficiency syndrome. Dig Dis Sci (1988) 1.11
Resting energy expenditure is increased in stable, malnourished HIV-infected patients. Am J Clin Nutr (1991) 1.09
HIV-1 and HIV-2 AIDS in African patients living in Paris. AIDS (1997) 1.07
Immunohistochemical evidence for human immunodeficiency virus-1 infection of liver Kupffer cells. Hum Pathol (1990) 1.06
Resting energy expenditure in human immunodeficiency virus-infected patients: comparison between patients with and without secondary infections. Am J Clin Nutr (1993) 1.05
Pulmonary complications of human immunodeficiency virus infection in Bujumbura, Burundi. Am Rev Respir Dis (1993) 1.04
Foscarnet in the treatment of cytomegalovirus retinitis in acquired immune deficiency syndrome. Ophthalmology (1989) 1.03
Cidofovir in AIDS-associated progressive multifocal leukoencephalopathy: a monocenter observational study with clinical and JC virus load monitoring. J Neurovirol (2001) 1.02
Cryptococcus neoformans infection in France: epidemiologic features of and early prognostic parameters for 76 patients who were infected with human immunodeficiency virus. Clin Infect Dis (1996) 1.02
HIV-1 detection in cervicovaginal secretions during pregnancy. AIDS (1997) 1.01
Acceptability and impact of zidovudine for prevention of mother-to-child human immunodeficiency virus-1 transmission in France. J Pediatr (1997) 1.01
Primary prevention with cotrimoxazole for HIV-1-infected adults: results of the pilot study in Dakar, Senegal. J Acquir Immune Defic Syndr (2001) 1.00
Vertical transmission of HIV-2. Lancet (1990) 1.00
Virological diagnosis of progressive multifocal leukoencephalopathy: detection of JC virus DNA in cerebrospinal fluid and brain tissue of AIDS patients. J Clin Microbiol (1993) 1.00
Remission of AIDS-associated intestinal microsporidiosis with highly active antiretroviral therapy. AIDS (1997) 0.99
Tuberculosis, human immunodeficiency virus infection, and malnutrition in Burundi. Nutrition (1999) 0.98
Multiple opportunistic infection in a male homosexual in France. Lancet (1982) 0.97
Mycobacterium celatum infection in two HIV-infected patients treated prophylactically with rifabutin. Eur J Clin Microbiol Infect Dis (1998) 0.97
Treatment of imported cases of falciparum malaria in France with halofantrine. Trans R Soc Trop Med Hyg (1986) 0.97
Failure of anti-malarial prophylaxis with mefloquine in Africa. Trans R Soc Trop Med Hyg (1991) 0.96
Plasmodium falciparum: drug sensitivity in vitro of isolates before and after adaptation to continuous culture. Exp Parasitol (1983) 0.95
Nutritional status of HIV-seropositive subjects in an AIDS clinic in Paris. Eur J Clin Nutr (1997) 0.95
Cerebellar syndrome in mild Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg (1988) 0.95
Mother-to-child transmission of HIV-2 infection from 1986 to 2007 in the ANRS French Perinatal Cohort EPF-CO1. Clin Infect Dis (2010) 0.94
Changes in blood CD8+ lymphocyte activation status and plasma HIV RNA levels during antiretroviral therapy. AIDS (1998) 0.94
Impact of iron loading on the activity of isoniazid or ethambutol in the treatment of murine tuberculosis. Int J Tuberc Lung Dis (2003) 0.94
Visceral leishmaniasis and HIV infection: unusual presentation with pleuropulmonary involvement, and effect of secondary prophylaxis. AIDS (1992) 0.94
[Epidemic of trichinosis of Egyptian origin. Apropos of 6 cases observed in Paris]. Ann Med Interne (Paris) (1976) 0.94
T cell changes after combined nucleoside analogue therapy in HIV primary infection. AIDS (1999) 0.94
Acute renal failure in patients over 80 years old: 25-years' experience. Intensive Care Med (2000) 0.94
Herpes simplex esophagitis in patients with AIDS: report of 34 cases. The Cooperative Study Group on Herpetic Esophagitis in HIV Infection. Clin Infect Dis (1996) 0.93
Frequent detection of HIV-1 in the gastric aspirates of neonates born to HIV-infected mothers. AIDS (1999) 0.93
Highly sensitive method for amplification of human immunodeficiency virus type 2 DNA. J Clin Microbiol (1998) 0.92
AIDS-associated Kaposi's sarcoma in female patients. AIDS (1991) 0.92
Comparison of plasma cytokine levels in African patients with HIV-1 and HIV-2 infection. AIDS (1994) 0.91
Recombinant interferon-alpha for chronic hepatitis C in patients positive for antibody to human immunodeficiency virus. Comité des Anti-Viraux. J Infect Dis (1992) 0.91
Clinical efficacy and pharmacokinetics of micronized halofantrine for the treatment of acute uncomplicated falciparum malaria in nonimmune patients. Am J Trop Med Hyg (1994) 0.91
Serratia marcescens prosthesis infection successfully treated with meropenem after imipenem failure. J Infect (2005) 0.91